0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Debt / Common Equity in the risk category include:
A ratio that measures the level of the debt relative to the book value of common equity.
Debt / Equity is defined as:
Total Debt
(/) Total Common Equity
(=) Debt / Equity
Debt / Equity for Inozyme Pharma is calculated as follows:
Total Debt [ 46.873 M]
(/) Total Common Equity [ 57.826 M ]
(=) Debt / Equity [ 81.1% ]
The tables below summarizes the trend in Inozyme Pharma’s Debt / Equity over the last five years:
| Fiscal Year | Total Debt | Total Common Equity | Debt / Equity |
|---|---|---|---|
| 2020-12-31 | zero | NA | 0.0% |
| 2021-12-31 | 3.371 M | 109.3 M | 3.1% |
| 2022-12-31 | 6.778 M | 118.4 M | 5.7% |
| 2023-12-31 | 46.592 M | 140.5 M | 33.2% |
| 2024-12-31 | 46.873 M | 57.826 M | 81.1% |
The tables below summarizes the trend in Inozyme Pharma’s Debt / Equity over the last four quarters:
| Fiscal Quarter | Total Debt | Total Common Equity | Debt / Equity |
|---|---|---|---|
| 2024-03-31 | 46.635 M | 118.8 M | 39.2% |
| 2024-06-30 | 46.71 M | 94.42 M | 49.5% |
| 2024-09-30 | 46.792 M | 82.788 M | 56.5% |
| 2024-12-31 | 46.873 M | 57.826 M | 81.1% |
The higher the ratio, the more debt the company has in its capital structure.
Read More on HBR: Debt / Equity Ratio
The chart above depicts the distribution of debt / common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,480 companies were considered in this analysis, and 2,388 had meaningful values. The average debt / common equity of companies in the sector is 29.4% with a standard deviation of 102.5%.
Inozyme Pharma Inc's Debt / Common Equity of 81.1% ranks in the 83.4% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,488 |
| Included Constituents | 2,388 |
| Min | -343.5% |
| Max | 688.6% |
| Median | 7.2% |
| Mean | 29.4% |
| Standard Deviation | 102.5% |
You can find companies with similar debt / common equity using this stock screener.